市場調査レポート
商品コード
991703

泌尿器デバイスの世界市場 (~2026年):製品 (透析・内視鏡・レーザー・砕石術・ロボットシステム・ガイドワイヤー・カテーテル・ステント)・用途 (腎臓病・泌尿器癌・BPH)・エンドユーザー (病院・透析センター・在宅医療)・地域別

Urology Devices Market by Product ((Dialysis, Endoscopes, Lasers, Lithotripsy, Robotic System), (Guidewires, Catheters, Stents)), Application(Kidney Diseases, Urological Cancer, BPH), End User(Hospital, Dialysis Center, Homecare)-Global Forecast to 2026

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 194 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.18円
泌尿器デバイスの世界市場 (~2026年):製品 (透析・内視鏡・レーザー・砕石術・ロボットシステム・ガイドワイヤー・カテーテル・ステント)・用途 (腎臓病・泌尿器癌・BPH)・エンドユーザー (病院・透析センター・在宅医療)・地域別
出版日: 2021年02月24日
発行: MarketsandMarkets
ページ情報: 英文 194 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の泌尿器デバイスの市場規模は予測期間中4.1%のCAGRで推移し、2021年の380億米ドルから、2026年には464億米ドルの規模に成長すると予測されています。

病院の増加、内視鏡検査および腹腔鏡検査施設への投資、泌尿器科疾患の発症率・有病率の上昇、低侵襲手術が好まれる傾向などの要因が同市場の成長を推進しています。一方、高度な市場統合が市場のさらなる成長をある程度抑制すると見通しです。

用途別で見ると、泌尿器がん・BPHの部門が予測期間中最大のCAGRを示す見通しです。高齢者人口の増加、泌尿器がんの発症生率の上昇などの要因が同部門の成長を牽引しています。エンドユーザー別では、透析センターの部門が最大のCAGRを示す見通しです。ESRD治療のための高度な透析製品および設備に対する需要の拡大が同部門の成長を牽引しています。

当レポートでは、世界の泌尿器デバイスの市場を調査し、市場の定義と概要、バリューチェーン、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、法規制環境、特許動向、価格動向、市場規模の推移・予測、製品・用途・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • COVID-19の影響
  • 価格分析
  • 特許分析
  • バリューチェーン分析
  • サプライチェーン分析
  • エコシステム分析
  • ポーターのファイブフォース分析
  • PESTLE分析
  • 規制状況
  • 貿易分析

第6章 市場分析・予測:製品別

  • 機器
    • 透析装置
    • 内視鏡
    • レーザー・砕石装置
    • エンドビジョン・イメージングシステム
    • ロボットシステム
    • 気腹装置
    • 内視鏡検査液管理システム
    • 尿流動態システム
  • 消耗品・付属品
    • 透析消耗品
    • カテーテル
    • ガイドワイヤー
    • 検索デバイス・抽出器
    • 外科用解剖器具・鉗子・持針器
    • 拡張セット・尿道アクセスシート
    • ステント
    • 生検装置
    • チューブ・遠位アタッチメント
    • 排水バッグ
    • その他

第7章 市場分析・予測:用途別

  • 腎臓病
  • 泌尿器がん・BPH
  • 骨盤底臓器脱
  • その他

第8章 市場分析・予測:エンドユーザー別

  • 病院・ASC・クリニック
  • 透析センター
  • 在宅医療

第9章 市場分析・予測:地域・主要国別

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他
  • ラテンアメリカ
  • 中東・アフリカ

第10章 競合情勢

  • 概要
  • 主要企業の戦略
  • 市場シェア分析
  • 企業評価クアドラント
  • スタートアップ:競合リーダーシップマッピング
  • 競合シナリオ

第11章 企業プロファイル

  • 主要企業
    • FRESENIUS MEDICAL CARE AG & CO. KGAA
    • BAXTER INTERNATIONAL, INC.
    • BOSTON SCIENTIFIC CORPORATION
    • BECTON, DICKINSON AND COMPANY
    • OLYMPUS CORPORATION
    • B. BRAUN MELSUNGEN AG
    • STRYKER CORPORATION
    • INTUITIVE SURGICAL
    • MEDTRONIC PLC
    • CARDINAL HEALTH
  • その他の企業
    • TELEFLEX INCORPORATED
    • KARL STORZ
    • COOK MEDICAL
    • RICHARD WOLF GMBH
    • COMPACTCATH
    • DORNIER MEDTECH
    • NIKKISO CO., LTD.
    • DIALIFE SA
    • MAXER ENDOSCOPY GMBH
    • WELL LEAD MEDICAL CO., LTD.
    • ROCAMED
    • ENDOMED SYSTEMS GMBH
    • AMSINO INTERNATIONAL, INC.
    • MEDISPEC
    • MEDICAL TECHNOLOGIES OF GEORGIA
    • VIMEX SP. Z O. O.
    • BALTON SP. Z O.O.
    • HUNTER UROLOGY
    • RIBBEL INTERNATIONAL LIMITED
    • J & M URINARY CATHETERS, LLC

第12章 付録

目次
Product Code: MD 4682

The global urology devices market is projected to reach USD 46.4 billion by 2026 from USD 38.0 billion in 2021, at a CAGR of 4.1% during the forecast period. Market growth is driven by factors such as the growing number of hospitals and investments in endoscopy and laparoscopy facilities, rising incidence and prevalence of urological conditions, and growing preference for minimally invasive procedures. On the other hand, the high degree of market consolidation is expected to limit market growth to a certain extent in the coming years.

"The consumables & accessories segment accounted for the highest growth rate in the urology devices market, by product, during the forecast period"

The urology devices market is segmented into instruments and consumables & accessories based on product. In 2020, the consumables & accessories segment accounted for the highest growth rate in the urology devices market. The requirement of consumables and accessories in large numbers as compared to instruments is the major factor contributing to the growth of this segment.

"Urological cancer and BPH segment accounted for the highest CAGR"

Based on applications, the urology devices market is segmented into kidney diseases, urological cancer and BPH, pelvic organ prolapse, and other applications. In 2020, the urological cancer and BPH segment accounted for the highest growth rate. The rising geriatric population and rising incidence of urological cancers are the major factors driving this segment's growth.

"Dialysis centers segment accounted for the highest CAGR"

Based on end users, the urology devices market is segmented into hospitals, ASCs, and clinics; dialysis centers; and home care settings. In 2020, the dialysis centers segment accounted for the highest growth rate. This can be attributed to the increased demand for advanced dialysis products and facilities for ESRD treatment.

"Asia Pacific: The fastest-growing region urology devices market"

The global urology devices market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Growth in this region is expected to be centered on China and Japan. Factors such as the rising geriatric population, increasing prevalence of diabetes, high burden of kidney diseases such as CKD, increasing healthcare spending, growing per capita income, rising demand for cutting-edge technologies, expansion of private-sector hospitals to rural areas in various APAC countries, and the presence of high-growth markets are driving the growth of the urology devices market in this region.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
  • By Designation: C-level - 27%, D-level - 18%, and Others - 55%
  • By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America - 6% , and the Middle East & Africa - 4%

Lists of Companies Profiled in the Report:

  • Fresenius Medical Care AG & Co. KGaA (Germany)
  • Baxter International Inc. (US)
  • Boston Scientific Corporation (US)
  • Becton, Dickinson and Company (US)
  • Olympus Corporation (Japan)
  • B. Braun Melsungen AG (Germany)
  • Stryker Corporation (US)
  • KARL STORZ (Germany)
  • Cook Medical (US)
  • Intuitive Surgical (US)
  • Medtronic plc (Ireland)
  • Cardinal Health (US)
  • Teleflex Incorporated (US)
  • Richard Wolf GmbH (Germany)
  • CompactCath (US)
  • Dornier MedTech (Germany)
  • Nikkiso Co., Ltd. (Japan)
  • Balton Sp. z o.o. (Poland)
  • Dialife SA (Switzerland)
  • Maxer Endoscopy GmbH (Germany)
  • Vimex Sp. z o.o. (Poland)
  • Amsino International, Inc. (US)
  • ROCAMED (Monaco)
  • Well Lead Medical Co., Ltd. (China)
  • Medispec (US)
  • Medical Technologies of Georgia (Georgia)
  • EndoMed Systems GmbH (Germany)
  • Hunter Urology (England)
  • J and M Urinary Catheters LLC (US)
  • Ribbel International Limited (India)

Research Coverage:

This report provides a detailed picture of the global urology devices market. It aims at estimating the size and future growth potential of the market across different segments, such as product, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall urology devices market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
    • 1.2.2 MARKETS COVERED
    • FIGURE 1 UROLOGY DEVICES MARKET SEGMENTATION
    • 1.2.3 YEARS CONSIDERED FOR THE STUDY
  • 1.3 CURRENCY
  • 1.4 LIMITATIONS
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH APPROACH
    • FIGURE 2 UROLOGY DEVICES MARKET: RESEARCH DESIGN
    • 2.2.1 SECONDARY DATA
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.3 MARKET SIZE ESTIMATION
    • 2.3.1 BOTTOM-UP APPROACH
    • FIGURE 4 UROLOGY DEVICES MARKET: BOTTOM-UP APPROACH
    • 2.3.2 TOP-DOWN APPROACH
    • FIGURE 5 UROLOGY DEVICES MARKET: TOP-DOWN APPROACH
  • 2.4 MARKET BREAKDOWN & DATA TRIANGULATION
    • FIGURE 6 DATA TRIANGULATION METHODOLOGY
  • 2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

    • FIGURE 7 UROLOGY DEVICES MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
    • FIGURE 8 UROLOGY DEVICES MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    • FIGURE 9 UROLOGY DEVICES MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
    • FIGURE 10 UROLOGY DEVICES MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)

4 PREMIUM INSIGHTS

  • 4.1 UROLOGY DEVICES MARKET OVERVIEW
    • FIGURE 11 RISING PREVALENCE OF UROLOGICAL CONDITIONS TO DRIVE MARKET GROWTH
  • 4.2 UROLOGY INSTRUMENTS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 12 DIALYSIS DEVICES SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2026
  • 4.3 UROLOGY ENDOSCOPES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 13 LAPAROSCOPES SEGMENT DOMINATES THE MARKET IN 2021
  • 4.4 UROLOGY DEVICES MARKET SHARE, BY END USER, 2021 VS. 2026
    • FIGURE 14 HOSPITALS, ASCS, & CLINICS ARE THE LARGEST END USERS OF UROLOGY DEVICES
  • 4.5 UROLOGY DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 15 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE UROLOGY DEVICES MARKET DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 16 UROLOGY DEVICES MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising incidence and prevalence of urological conditions
    • TABLE 1 GLOBAL PREVALENCE OF URINARY INCONTINENCE
    • TABLE 2 GLOBAL UROLOGIC CANCER INCIDENCE
    • TABLE 3 GLOBAL INCIDENCE & PREVALENCE OF PROSTATE CANCER
      • 5.2.1.2 Growing preference for minimally invasive procedures
      • 5.2.1.3 Growing number of hospitals and investments in endoscopy and laparoscopy facilities
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High degree of consolidation
      • 5.2.2.2 High cost of urology devices
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emerging markets offer lucrative opportunities
  • 5.3 IMPACT OF COVID-19 ON THE UROLOGY DEVICES MARKET
  • 5.4 PRICING ANALYSIS
    • TABLE 4 PRICES OF UROLOGY DEVICES (2020)
  • 5.5 PATENT ANALYSIS
  • 5.6 VALUE CHAIN ANALYSIS
    • FIGURE 17 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASE
  • 5.7 SUPPLY CHAIN ANALYSIS
    • FIGURE 18 DISTRIBUTION-A STRATEGY PREFERRED BY PROMINENT COMPANIES
  • 5.8 ECOSYSTEM ANALYSIS OF THE UROLOGY DEVICES MARKET
    • FIGURE 19 ECOSYSTEM ANALYSIS OF THE UROLOGY DEVICES MARKET
  • 5.9 PORTER'S FIVE FORCES ANALYSIS
    • FIGURE 20 HIGH CAPITAL INVESTMENTS TO RESTRICT THE ENTRY OF NEW PLAYERS
    • 5.9.1 THREAT OF NEW ENTRANTS
    • 5.9.2 THREAT OF SUBSTITUTES
    • 5.9.3 BARGAINING POWER OF BUYERS
    • 5.9.4 BARGAINING POWER OF SUPPLIERS
    • 5.9.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.10 PESTLE ANALYSIS
  • 5.11 REGULATORY LANDSCAPE
    • 5.11.1 NORTH AMERICA
      • 5.11.1.1 US
      • 5.11.1.2 Canada
    • 5.11.2 EUROPE
    • 5.11.3 ASIA PACIFIC
      • 5.11.3.1 China
      • 5.11.3.2 Japan
      • 5.11.3.3 India
      • 5.11.3.4 South Korea
    • 5.11.4 LATIN AMERICA
      • 5.11.4.1 Brazil
      • 5.11.4.2 Mexico
    • 5.11.5 MIDDLE EAST
    • 5.11.6 AFRICA
  • 5.12 TRADE ANALYSIS
    • 5.12.1 TRADE ANALYSIS FOR DIALYSIS INSTRUMENTS
      • 5.12.1.1 Import data for dialysis instruments, by country, 2016-2020 (USD Million)
    • 5.12.2 TRADE ANALYSIS FOR ENDOSCOPES
      • 5.12.2.1 Import data for endoscopes, by country, 2016-2020 (USD Million)

6 UROLOGY DEVICES MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 5 UROLOGY DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
  • 6.2 INSTRUMENTS
    • TABLE 6 UROLOGY INSTRUMENTS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 7 UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 6.2.1 DIALYSIS DEVICES
    • TABLE 8 DIALYSIS DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 9 DIALYSIS DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
      • 6.2.1.1 Hemodialysis devices
        • 6.2.1.1.1 HHD has gained significance due to improved clinical outcomes for patients
    • TABLE 10 HEMODIALYSIS DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 6.2.1.2 Peritoneal dialysis devices
        • 6.2.1.2.1 Technological advancements in PD devices and increasing product approvals to propel market growth
    • TABLE 11 PERITONEAL DIALYSIS DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.2.2 ENDOSCOPES
    • TABLE 12 ENDOSCOPES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 13 ENDOSCOPES MARKET, BY TYPE, 2019-2026 (USD MILLION)
      • 6.2.2.1 Laparoscopes
        • 6.2.2.1.1 Growing number of laparoscopy procedures to support the market growth
    • TABLE 14 LAPAROSCOPES MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 6.2.2.2 Ureteroscopes
        • 6.2.2.2.1 Continuous technological advancements to support the growth of this market
    • TABLE 15 URETEROSCOPES MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 6.2.2.3 Nephroscopes
        • 6.2.2.3.1 High cost of maintenance to restrain the market growth
    • TABLE 16 NEPHROSCOPES MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 6.2.2.4 Resectoscopes
        • 6.2.2.4.1 High prevalence of prostate, kidney, and bladder cancers to drive the demand for resectoscopes
    • TABLE 17 RESECTOSCOPES MARKET, BY REGION, 2019-2026 (USD MILLION)
      • 6.2.2.5 Cystoscopes
        • 6.2.2.5.1 Increasing prevalence and incidence of urological cancers to drive the uptake to cystoscopes for early diagnosis and treatment
    • TABLE 18 CYSTOSCOPES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.2.3 LASER & LITHOTRIPSY DEVICES
      • 6.2.3.1 Increasing prevalence of kidney diseases to support market growth
    • TABLE 19 LASER & LITHOTRIPSY DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.2.4 ENDOVISION & IMAGING SYSTEMS
      • 6.2.4.1 Need for high-resolution images for better observation of body cavities and organs to propel the market in the coming years
    • TABLE 20 ENDOVISION & IMAGING SYSTEMS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.2.5 ROBOTIC SYSTEMS
      • 6.2.5.1 Growing industry-academia collaborations to support market growth
    • TABLE 21 ROBOTIC SYSTEMS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.2.6 INSUFFLATORS
      • 6.2.6.1 Increasing volume of laparoscopic procedures to boost the demand for insufflators
    • TABLE 22 INSUFFLATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.2.7 ENDOSCOPY FLUID MANAGEMENT SYSTEMS
      • 6.2.7.1 Growing incidence of chronic diseases to drive the market growth
    • TABLE 23 ENDOSCOPY FLUID MANAGEMENT SYSTEMS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.2.8 URODYNAMIC SYSTEMS
      • 6.2.8.1 Growing patient pool to support the growth of this product segment
    • TABLE 24 URODYNAMIC SYSTEMS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 6.3 CONSUMABLES & ACCESSORIES
    • TABLE 25 UROLOGY CONSUMABLES & ACCESSORIES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 26 UROLOGY CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 6.3.1 DIALYSIS CONSUMABLES
      • 6.3.1.1 Growing number of dialysis procedures to support market growth
    • TABLE 27 DIALYSIS CONSUMABLES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.3.2 CATHETERS
      • 6.3.2.1 High prevalence of urinary incontinence will drive the market for catheters
    • TABLE 28 CATHETERS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.3.3 GUIDEWIRES
      • 6.3.3.1 Development of next-generation hybrid guidewires has created significant growth opportunities
    • TABLE 29 GUIDEWIRES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.3.4 RETRIEVAL DEVICES & EXTRACTORS
      • 6.3.4.1 Technological advancements to support market growth
    • TABLE 30 UROLOGY DEVICES MARKET FOR RETRIEVAL DEVICES & EXTRACTORS, BY REGION, 2019-2026 (USD MILLION)
    • 6.3.5 SURGICAL DISSECTORS, FORCEPS, & NEEDLE HOLDERS
      • 6.3.5.1 Growing number of urology procedures to support market growth
    • TABLE 31 SURGICAL DISSECTORS, FORCEPS, & NEEDLE HOLDERS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.3.6 DILATOR SETS & URETHRAL ACCESS SHEATHS
      • 6.3.6.1 Growing demand for effective endoscopic management of ureteral and renal calculi to support market growth
    • TABLE 32 DILATOR SETS & URETHRAL ACCESS SHEATHS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.3.7 STENTS
      • 6.3.7.1 Growing prevalence of urological and kidney-related disorders to propel market growth
    • TABLE 33 STENTS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.3.8 BIOPSY DEVICES
      • 6.3.8.1 High incidence of prostate cancer to drive the uptake of biopsy devices
    • TABLE 34 BIOPSY DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.3.9 TUBES & DISTAL ATTACHMENTS
      • 6.3.9.1 Growing demand for endoscopy is expected to propel the growth of this segment
    • TABLE 35 TUBES & DISTAL ATTACHMENTS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.3.10 DRAINAGE BAGS
      • 6.3.10.1 Risk of urinary tract infections and skin irritation to restrain the market growth
    • TABLE 36 DRAINAGE BAGS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.3.11 OTHER CONSUMABLES & ACCESSORIES
    • TABLE 37 OTHER CONSUMABLES & ACCESSORIES MARKET, BY REGION, 2019-2026 (USD MILLION)

7 UROLOGY DEVICES MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
    • TABLE 38 UROLOGY DEVICES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
  • 7.2 KIDNEY DISEASES
    • 7.2.1 GROWING PREVALENCE OF DIABETES AND HYPERTENSION TO SUPPORT MARKET GROWTH
    • TABLE 39 UROLOGY DEVICES MARKET FOR KIDNEY DISEASES, BY REGION, 2019-2026 (USD MILLION)
  • 7.3 UROLOGICAL CANCER & BPH
    • 7.3.1 RISING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO DRIVE THE MARKET GROWTH
    • TABLE 40 UROLOGY DEVICES MARKET FOR UROLOGICAL CANCER & BPH, BY REGION, 2019-2026 (USD MILLION)
  • 7.4 PELVIC ORGAN PROLAPSE
    • 7.4.1 HIGH COSTS INVOLVED IN SURGERIES & HIGH REOCCURRENCE RATES TO RESTRAIN THE MARKET GROWTH
    • TABLE 41 UROLOGY DEVICES MARKET FOR PELVIC ORGAN PROLAPSE, BY REGION, 2019-2026 (USD MILLION)
  • 7.5 OTHER APPLICATIONS
    • TABLE 42 UROLOGY DEVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)

8 UROLOGY DEVICES MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 43 UROLOGY DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 8.2 HOSPITALS, ASCS, & CLINICS
    • 8.2.1 HOSPITALS, ASCS, & CLINICS ARE THE LARGEST END USERS OF UROLOGY DEVICES
    • TABLE 44 UROLOGY DEVICES MARKET FOR HOSPITALS, ASCS, & CLINICS, BY REGION, 2019-2026 (USD MILLION)
  • 8.3 DIALYSIS CENTERS
    • 8.3.1 CHANGING REIMBURSEMENT POLICIES IN DEVELOPED COUNTRIES TO RESTRAIN THE MARKET GROWTH
    • TABLE 45 NUMBER OF DIALYSIS CENTERS IN THE US, BY COMPANY, 2019
    • TABLE 46 NUMBER OF DIALYSIS CENTERS IN CHINA, 2018
    • TABLE 47 UROLOGY DEVICES MARKET FOR DIALYSIS CENTERS, BY REGION, 2019-2026 (USD MILLION)
  • 8.4 HOME CARE SETTINGS
    • 8.4.1 IMPROVED PATIENT OUTCOMES AND SHORTER HOSPITAL STAYS TO SUPPORT MARKET GROWTH
    • TABLE 48 UROLOGY DEVICES MARKET FOR HOME CARE SETTINGS, BY REGION, 2019-2026 (USD MILLION)

9 UROLOGY DEVICES MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 49 UROLOGY DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 21 NORTH AMERICA: UROLOGY DEVICES MARKET SNAPSHOT
    • TABLE 50 NORTH AMERICA: UROLOGY DEVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 51 NORTH AMERICA: UROLOGY DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 52 NORTH AMERICA: UROLOGY DEVICES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 53 NORTH AMERICA: UROLOGY DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 The US dominates the North American urology devices market
    • TABLE 54 US: UROLOGY DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 55 US: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 56 US: UROLOGY DEVICES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 57 US: UROLOGY DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 Rising prevalence of target diseases to drive market growth in Canada
    • TABLE 58 CANADA: UROLOGY DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 59 CANADA: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 60 CANADA: UROLOGY DEVICES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 61 CANADA: UROLOGY DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 62 EUROPE: UROLOGY DEVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 63 EUROPE: UROLOGY DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 64 EUROPE: UROLOGY DEVICES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 65 EUROPE: UROLOGY DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.1 GERMANY
      • 9.3.1.1 Germany to dominate the European urology devices market during the forecast period
    • TABLE 66 GERMANY: UROLOGY DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 67 GERMANY: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 68 GERMANY: UROLOGY DEVICES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 69 GERMANY: UROLOGY DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.2 UK
      • 9.3.2.1 Rising incidence of kidney conditions to drive market growth in the UK
    • TABLE 70 UK: UROLOGY DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 71 UK: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 72 UK: UROLOGY DEVICES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 73 UK: UROLOGY DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.3 FRANCE
      • 9.3.3.1 Favorable government initiatives are supporting the market growth in France
    • TABLE 74 FRANCE: UROLOGY DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 75 FRANCE: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 76 FRANCE: UROLOGY DEVICES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 77 FRANCE: UROLOGY DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.4 ITALY
      • 9.3.4.1 Favorable medical and healthcare reimbursements are driving the market growth in Italy
    • TABLE 78 ITALY: UROLOGY DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 79 ITALY: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 80 ITALY: UROLOGY DEVICES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 81 ITALY: UROLOGY DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.5 SPAIN
      • 9.3.5.1 Rising prevalence of CKD in Spain to drive market growth
    • TABLE 82 SPAIN: UROLOGY DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 83 SPAIN: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 84 SPAIN: UROLOGY DEVICES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 85 SPAIN: UROLOGY DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.6 REST OF EUROPE
    • TABLE 86 ROE: NUMBER OF CANCER CASES, BY COUNTRY, 2018
    • TABLE 87 ROE: UROLOGY DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 88 ROE: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 89 ROE: UROLOGY DEVICES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 90 ROE: UROLOGY DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 22 ASIA PACIFIC: UROLOGY DEVICES MARKET SNAPSHOT
    • TABLE 91 APAC: UROLOGY DEVICES MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 92 APAC: UROLOGY DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 93 APAC: UROLOGY DEVICES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 94 APAC: UROLOGY DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.4.1 CHINA
      • 9.4.1.1 China accounts for the largest share of the APAC market
    • TABLE 95 CHINA: UROLOGY DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 96 CHINA: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 97 CHINA: UROLOGY DEVICES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 98 CHINA: UROLOGY DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.4.2 JAPAN
      • 9.4.2.1 Favorable regulatory framework in Japan to support the market growth
    • TABLE 99 JAPAN: UROLOGY DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 100 JAPAN: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 101 JAPAN: UROLOGY DEVICES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 102 JAPAN: UROLOGY DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.4.3 INDIA
      • 9.4.3.1 Healthcare infrastructure improvements and implementation of favorable government initiatives to support market growth in India
    • TABLE 103 INDIA: UROLOGY DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 104 INDIA: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 105 INDIA: UROLOGY DEVICES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 106 INDIA: UROLOGY DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.4.4 REST OF ASIA PACIFIC
    • TABLE 107 ROAPAC: UROLOGY DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 108 ROAPAC: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 109 ROAPAC: UROLOGY DEVICES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 110 ROAPAC: UROLOGY DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.5 LATIN AMERICA
    • 9.5.1 HIGH PREVALENCE OF CHRONIC CONDITIONS TO DRIVE MARKET GROWTH
    • TABLE 111 LATIN AMERICA: UROLOGY DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 112 LATIN AMERICA: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 113 LATIN AMERICA: UROLOGY DEVICES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 114 LATIN AMERICA: UROLOGY DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 INCREASING HEALTHCARE EXPENDITURE TO DRIVE THE MARKET GROWTH
    • TABLE 115 MIDDLE EAST & AFRICA: UROLOGY DEVICES MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 116 MIDDLE EAST & AFRICA: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 117 MIDDLE EAST & AFRICA: UROLOGY DEVICES MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 118 MIDDLE EAST & AFRICA: UROLOGY DEVICES MARKET, BY END USER, 2019-2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGIES
  • 10.3 MARKET SHARE ANALYSIS
    • FIGURE 23 UROLOGY DEVICES MARKET SHARE, BY KEY PLAYER (2019)
  • 10.4 COMPANY EVALUATION QUADRANT
    • 10.4.1 LIST OF EVALUATED VENDORS
    • 10.4.2 STARS
    • 10.4.3 EMERGING LEADERS
    • 10.4.4 PERVASIVE PLAYERS
    • 10.4.5 PARTICIPANTS
    • FIGURE 24 UROLOGY DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019
  • 10.5 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS (2019)
    • 10.5.1 PROGRESSIVE COMPANIES
    • 10.5.2 STARTING BLOCKS
    • 10.5.3 RESPONSIVE COMPANIES
    • 10.5.4 DYNAMIC COMPANIES
    • FIGURE 25 UROLOGY DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES, 2019
  • 10.6 COMPETITIVE SCENARIO
    • 10.6.1 MARKET EVALUATION FRAMEWORK, 2018-2020
    • 10.6.2 PRODUCT LAUNCHES & APPROVALS
    • TABLE 119 KEY PRODUCT LAUNCHES & APPROVALS
    • 10.6.3 EXPANSIONS
    • TABLE 120 KEY EXPANSIONS
    • 10.6.4 ACQUISITIONS
    • TABLE 121 KEY ACQUISITIONS
    • 10.6.5 PARTNERSHIPS, COLLABORATIONS, & JOINT VENTURES
    • TABLE 122 KEY PARTNERSHIPS, COLLABORATIONS, & JOINT VENTURES

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
  • (Business Overview, Products Offered, Recent Developments, MnM View)**
    • 11.1.1 FRESENIUS MEDICAL CARE AG & CO. KGAA
    • FIGURE 26 FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY SNAPSHOT (2019)
    • 11.1.2 BAXTER INTERNATIONAL, INC.
    • FIGURE 27 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT (2019)
    • 11.1.3 BOSTON SCIENTIFIC CORPORATION
    • FIGURE 28 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2019)
    • 11.1.4 BECTON, DICKINSON AND COMPANY
    • FIGURE 29 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
    • 11.1.5 OLYMPUS CORPORATION
    • FIGURE 30 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2020)
    • 11.1.6 B. BRAUN MELSUNGEN AG
    • FIGURE 31 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2019)
    • 11.1.7 STRYKER CORPORATION
    • FIGURE 32 STRYKER CORPORATION: COMPANY SNAPSHOT (2019)
    • 11.1.8 INTUITIVE SURGICAL
    • FIGURE 33 INTUITIVE SURGICAL: COMPANY SNAPSHOT (2019)
    • 11.1.9 MEDTRONIC PLC
    • FIGURE 34 MEDTRONIC PLC: COMPANY SNAPSHOT (2020)
    • 11.1.10 CARDINAL HEALTH
    • FIGURE 35 CARDINAL HEALTH: COMPANY SNAPSHOT (2020)
  • 11.2 OTHER PLAYERS
    • 11.2.1 TELEFLEX INCORPORATED
    • FIGURE 36 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2019)
    • 11.2.2 KARL STORZ
    • 11.2.3 COOK MEDICAL
    • 11.2.4 RICHARD WOLF GMBH
    • 11.2.5 COMPACTCATH
    • 11.2.6 DORNIER MEDTECH
    • 11.2.7 NIKKISO CO., LTD.
    • 11.2.8 DIALIFE SA
    • 11.2.9 MAXER ENDOSCOPY GMBH
    • 11.2.10 WELL LEAD MEDICAL CO., LTD.
    • 11.2.11 ROCAMED
    • 11.2.12 ENDOMED SYSTEMS GMBH
    • 11.2.13 AMSINO INTERNATIONAL, INC.
    • 11.2.14 MEDISPEC
    • 11.2.15 MEDICAL TECHNOLOGIES OF GEORGIA
    • 11.2.16 VIMEX SP. Z O. O.
    • 11.2.17 BALTON SP. Z O.O.
    • 11.2.18 HUNTER UROLOGY
    • 11.2.19 RIBBEL INTERNATIONAL LIMITED
    • 11.2.20 J & M URINARY CATHETERS, LLC
  • *Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 INSIGHTS FROM INDUSTRY EXPERTS
  • 12.2 DISCUSSION GUIDE
  • 12.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4 AVAILABLE CUSTOMIZATIONS
  • 12.5 RELATED REPORTS
  • 12.6 AUTHOR DETAILS